Tony Kouzarides is a Royal Society Professor at the University of Cambridge and Deputy Director of the Gurdon Institute. He did his PhD at the University of Cambridge and postdoctoral work at MRC Laboratory of Molecular Biology and at New York University Medical Center. He has been at the Gurdon Institute since his return from the USA. His lab works on the role of chromatin modifications in transcription and cancer.
Tony is on the Science Strategy Advisory Group of Cancer Research UK and on the Scientific Advisory Board for 4 Institutes in Europe. He is a founder and director of a charity (Conquer Cancer), based in Spain which raises public funds for cancer research. He is a founder of Chroma therapeutics, a UK based cancer drug discovery company which has as its focus enzymes that modify chromatin. He is a founder and director of Abcam plc, a publicly trading antibody reagents company. He has been awarded the Wellcome Trust medal for research in biochemistry related to medicine (UK), the Tenovus Medal (UK), the Bodossaki Foundation prize in Biology (Greece), the Bijvoet Medal (Holland) and the Novartis Medal and Prize (UK).
« Go Back